Search for 'Provider:Clinical and au:Carreira Delgado, Patricia Esmeralda and itype:ART'

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2013 . 31(2 Suppl 76):96-102. , Formato Vancouver: Heijnen IA, Foocharoen C, Bannert B, Carreira PE, Caporali R, Smith V et al. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study. Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):96-102.

Place Hold on Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.

By Carreira Delgado, Patricia Esmeralda. Journal of clinical epidemiology, 2014 . 67(6):706-14. , Formato Vancouver: Johnson SR, Naden RP, Fransen J, Van den Hoogen F, Pope JE, Baron M et al. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. J Clin Epidemiol. 2014 Jun;67(6):706-14.

Place Hold on Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.

An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2015 . 33(4 Suppl 91):S47-54. , Formato Vancouver: Brand M, Hollaender R, Rosenberg D, Scott M, Hunsche E, Tyndall A et al; EUSTAR Co-Investigators. An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S47-54.

Place Hold on An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database.

Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2015 . 33(4 Suppl 91):S75-9. , Formato Vancouver: Sandmeier B, Jäger VK, Nagy G, Carreira PE, Tzankov A, Widuchowska M et al. Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S75-9.

Place Hold on Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database.

Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2015 . 33(4 Suppl 91):S31-5. , Formato Vancouver: Ochoa E, Martín JE, Assasi S, Beretta L, Carreira P, Guillén A et al; Spanish Scleroderma Group. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S31-5.

Place Hold on Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.

Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2016 . 34 Suppl 100(5):92-99. , Formato Vancouver: Jewett LR, Kwakkenbos L, Carrier ME, Malcarne VL, Bartlett SJ, Furst DE et al; the SPIN Investigators. Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):92-99.

Place Hold on Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.